Cargando…
Orlistat in the prevention of diabetes in the obese patient
There has been an increase in the concern about preventing type 2 diabetes mellitus (T2DM), a disease with great and increasing prevalence. The prevalence of obesity, physical inactivity, Western processed diet, important risk factors for the development of T2DM, are also rising. Free fatty acids ar...
Autores principales: | Mancini, Marcio C, Halpern, Alfredo |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2496972/ https://www.ncbi.nlm.nih.gov/pubmed/18561508 |
Ejemplares similares
-
Efficacy and Tolerability of the Association of Sibutramine and
Orlistat for Six Months in Overweight and Obese Patients
por: Halpern, Alfredo, et al.
Publicado: (2010) -
Obesity management: Update on orlistat
por: Drew, Belinda S, et al.
Publicado: (2007) -
Evaluation of efficacy and safety of orlistat in obese patients
por: Jain, Suyog S., et al.
Publicado: (2011) -
The Effect of Orlistat on Sterol Metabolism in Obese Patients
por: Kwon, Yu-Jin, et al.
Publicado: (2022) -
Comparison of orlistat and orlistat plus metformin therapy between diabetic and nondiabetic groups
por: Gunay, Yasemin Emur, et al.
Publicado: (2023)